Monsanto Company (MON)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Monsanto Company (MON) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013397
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Monsanto Company (Monsanto) is an agricultural products manufacturing company. It develops and delivers agricultural products to support farmers all around the world. The company develops biotechnology traits that assist farmers in controlling insects and weeds. Monsanto also provides other seed companies with genetic material and biotechnology traits for their seed brands. The product line of the company includes agricultural and vegetable seeds, plant biotechnology traits and crop protection chemicals. The company operates in North America, South America, Europe, Asia, Australia and Africa; and has worldwide distribution, and sales and marketing network for its seeds and traits. Monsanto is headquartered in St. Louis, Missouri, the US.

Monsanto Company (MON) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Monsanto Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Monsanto Company, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Monsanto Company, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Monsanto Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Monsanto Company, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Monsanto Company, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
RaNA Therapeutics Raises Additional US$18 Million In Series A Financing 10
Licensing Agreements 12
Tekmira Enters Into Option For Licensing Agreement With Monsanto 12
Acquisition 13
Bayer to Acquire Monsanto for USD66 Billion 13
Monsanto Invests In Synthetic Genomics, Developer Of Genomic-Driven Solutions 15
Monsanto Acquires Divergence 16
Monsanto Company – Key Competitors 17
Monsanto Company – Key Employees 18
Monsanto Company – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Monsanto Company, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Monsanto Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Monsanto Company, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Monsanto Company, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Monsanto Company, Deals By Therapy Area, 2011 to YTD 2017 8
Monsanto Company, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
RaNA Therapeutics Raises Additional US$18 Million In Series A Financing 10
Tekmira Enters Into Option For Licensing Agreement With Monsanto 12
Bayer to Acquire Monsanto for USD66 Billion 13
Monsanto Invests In Synthetic Genomics, Developer Of Genomic-Driven Solutions 15
Monsanto Acquires Divergence 16
Monsanto Company, Key Competitors 17
Monsanto Company, Key Employees 18
Monsanto Company, Other Locations 19
Monsanto Company, Subsidiaries 20
Monsanto Company, Joint Venture 23

★海外企業調査レポート[Monsanto Company (MON)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kamada Ltd (KMDA):企業の財務・戦略的SWOT分析
    Kamada Ltd (KMDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Jacobs Engineering Group Inc (JEC):電力:M&Aディール及び事業提携情報
    Summary Jacobs Engineering Group Inc (Jacobs) is a professional services company. It offers a diverse range of technical, professional, and construction services. The company's service portfolio includes project; process, scientific and specialty consulting; engineering and construction; and operati …
  • Fujifilm Holdings Corporation (FUJIY):製薬・医療:M&Aディール及び事業提携情報
    Summary Fujifilm Holdings Corp (Fujifilm) sales and manufactures imaging systems and document solution equipment. The company’s major products are color films, color paper and chemicals, photofinishing equipment, electronic imaging and optical devices, TV camera lenses, security lenses, healthcare p …
  • Romaero SA Bucuresti:企業の戦略・SWOT・財務情報
    Romaero SA Bucuresti - Strategy, SWOT and Corporate Finance Report Summary Romaero SA Bucuresti - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ecobee Inc:電力:M&Aディール及び事業提携情報
    Summary Ecobee Inc (Ecobee) is a thermostat device provider. The company offers ecobee swith plus, ecobee four, ecobee four smarter bundle, ecobee three lite, ecobee three lite smarter bundle, refurbished ecobee three, EMS Si and room sensors. Its products are controlled through voice control and mo …
  • eLong, Inc.:企業の戦略・SWOT・財務情報
    eLong, Inc. - Strategy, SWOT and Corporate Finance Report Summary eLong, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Hang Seng Bank Ltd:企業の戦略・SWOT・財務分析
    Hang Seng Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Hang Seng Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Occidental Chemical Corp:企業の戦略的SWOT分析
    Occidental Chemical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Hobby Lobby Stores Inc:戦略・SWOT・企業財務分析
    Hobby Lobby Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Hobby Lobby Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • TALi Digital Ltd (NHL):企業の財務・戦略的SWOT分析
    TALi Digital Ltd (NHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • RFIB Group Limited:企業の戦略・SWOT・財務情報
    RFIB Group Limited - Strategy, SWOT and Corporate Finance Report Summary RFIB Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Latvenergo AS:企業の戦略的SWOT分析
    Latvenergo AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Empire Genomics LLC:医療機器:M&Aディール及び事業提携情報
    Summary Empire Genomics LLC (Genomics) is a medical device company that offers clinical molecular diagnostic solutions. The company provides ID labs products, fish probes, BAC clones, and genotyping and circulating tumor cell products. Its ID lab products include cytogenetics media, cytogenetics pro …
  • Ameren Corporation:企業の戦略・SWOT・財務情報
    Ameren Corporation - Strategy, SWOT and Corporate Finance Report Summary Ameren Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sohu.com Ltd. (SOHU):企業の財務・戦略的SWOT分析
    Sohu.com Ltd. (SOHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • The Nippon Synthetic Chemical Industry Co Ltd:企業の戦略的SWOT分析
    The Nippon Synthetic Chemical Industry Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • QPR Software Oyj (QPR1V):企業の財務・戦略的SWOT分析
    Summary QPR Software Oyj (QPR) is a technology company that provides software and solutions support. The company’s products include QPR business operating system, QPR process analyzer, QPR enterprise architect, QPR process designer, QPR metrics and QPR connectors. It offers solutions such as interna …
  • Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析
    Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Sitara Chemical Industries Ltd (SITC)
    Sitara Chemical Industries Ltd (SITC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Contango Oil & Gas Co (MCF):企業の財務・戦略的SWOT分析
    Summary Contango Oil & Gas Co (Contango) is an oil and natural gas company that explores, exploits, develops, produces and acquires crude oil and natural gas properties. The company provides operation for both offshore and onshore producing assets. Its offshore operations comprise Vermilion 170 plat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆